These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36160460)

  • 1. Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma.
    Xia QX; Yu J; Wang ZJ; Guan QW; Mao XY
    Front Pharmacol; 2022; 13():990461. PubMed ID: 36160460
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification.
    Jiang C; Wang M; Yao W; Lv G; Liu X; Wang G
    Front Mol Biosci; 2022; 9():778857. PubMed ID: 35433829
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion
    Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ
    PeerJ; 2024; 12():e17579. PubMed ID: 38978755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
    Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
    Front Oncol; 2021; 11():654350. PubMed ID: 33954112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.
    Yin L; Xu Y; Yin J; Cheng H; Xiao W; Wu Y; Ji D; Gao S
    Front Mol Neurosci; 2023; 16():1304224. PubMed ID: 38115820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis.
    Ramos S; Ferreira S; Fernandes AS; Saraiva N
    Front Pharmacol; 2022; 13():883998. PubMed ID: 35800439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods.
    Zhang H; Huang Y; Yang E; Gao X; Zou P; Sun J; Tian Z; Bao M; Liao D; Ge J; Yang Q; Li X; Zhang Z; Luo P; Jiang X
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
    Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q
    Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection.
    Yi X; Zhou Y; Chen Y; Feng X; Liu C; Jiang DS; Geng J; Li X; Jiang X; Fang ZM
    Front Cardiovasc Med; 2021; 8():692856. PubMed ID: 34307505
    [No Abstract]   [Full Text] [Related]  

  • 18. High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma.
    Guo Q; Gao X; Li J; Liu Y; Liu J; Yang H; Cui M; Zhang M; Duan L; Ma X
    Sci Rep; 2023 Mar; 13(1):3820. PubMed ID: 36882457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the lysyl oxidase family in ovarian cancer.
    Ye M; Zhou J; Gao Y; Pan S; Zhu X
    J Clin Lab Anal; 2020 Dec; 34(12):e23538. PubMed ID: 33058284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.